Authors


Morgan Petronelli

Latest:

Study assesses impact of health literacy on chronic pelvic pain

Addressing the gaps in health literacy may lead to improvement in health outcomes and health care disparities among patients with chronic pelvic pain.


Austin Ward

Latest:

Automated medical coding benefits both the practice and the patients

When you add automation, your medical coding not only improves your margins but also plays a key role in improving patient care.


Paul E. Dato, MD

Latest:

The Role of Bone-Targeted Therapies

Paul E. Dato, MD, discusses how bone-targeted therapies play an important supportive role in advanced prostate cancer, with recommendations for calcium and vitamin D supplementation, vitamin K2 consideration, resistance exercises, and regular monitoring for all patients on ADT.


Quoc-Dien Trinh, MD, MPH

Latest:

Remaining unmet needs in diverse populations with mHSPC

Enhancing minority enrollment in clinical trials and utilizing real-world data improves drug safety and efficacy for mHSPC treatments.


Lourdes Guerrios Rivera, MD, MSc

Latest:

What the SWIU Census reveals about the state of women in urology

"As the number of women urologists continues to increase, the field of urology must pay attention to their needs and professional satisfaction as they will constitute an increasing proportion of the future urologic work force," writes Lourdes Guerrios Rivera, MD, MSc.


Denise Juhr

Latest:

Urologic research and COVID-19: Unmasking the silver lining

In this column, the authors discuss how the coronavirus disease 2019 (COVID-19) shutdown yielded unexpected opportunities in urologic research.


Hannah Slater

Latest:

Treatment at high-volume facilities linked to improved survival in node-positive prostate cancer

The improved survival was observed in patients treated at high-volume radiation centers with external-beam radiation therapy plus androgen-deprivation therapy.


Jonathan Henderson, MD

Latest:

“Shooting for the Moon” means reducing metastatic prostate cancer diagnoses

“We have an incredible opportunity to save countless more lives with better screening practices and renewed recommendations, which accurately reflect the realities we as independent physicians see within our patient populations every day,” Jonathan Henderson, MD, writes in this letter to the editor.


Eric A. Singer, MD, MA, FACS

Latest:

Clinical Pearls and Future of Bladder Cancer Treatment

Eric A. Singer, MD, MA, FACS, looks to the future of bladder cancer treatment and offers advice for community urologists and urologic oncologists treating patients with the disease.


Alan H. Bryce, MD

Latest:

Urologic implications of Lynch syndrome

Research indicates Lynch syndrome is associated with urothelial, prostate, and other urologic cancers.


Francesca A. Williamson, PhD

Latest:

Is video-based research feasible for pediatric urology visits?

"This first paper was really to show that our research methodology was feasible and acceptable with pediatric urology patients and families. We've done that, and now we have a huge corpus of data that we can further analyze through empirical studies," says Francesca A. Williamson, PhD.


Bryn Launer, MD

Latest:

Considerations for palliative care in urologic oncology

Benefits include improved quality of life and symptom management.


United Urology Group

Latest:

United Urology Group and its affiliate practices and Prostate Centers USA® are collaborating to revolutionize men's health care with minimally invasive solutions

The inclusion of PAE in the American Urological Association BPH Guidelines offers a non-surgical alternative that can provide long-term relief with minimal downtime and fewer complications, according to the United Urology Group.


Maria Uloko, MD

Latest:

Maria Uloko, MD, on the need for better education on female sexual dysfunction

"My goal [for] a lot of the advocacy that I do is that one day [patients] don't have to do our jobs for us," says Maria Uloko, MD.


Colleen Moretti

Latest:

Triplet therapy including darolutamide should be standard of care in mCSPC, data indicate

Results of the ARASENS trial (NCT02799602) demonstrated that darolutamide plus ADT and docetaxel prolonged overall survival regardless of disease volume or risk.


Brielle Benyon

Latest:

Real-world data point to underutilization of germline, somatic testing in mCRPC

"Certainly germline and somatic is recommended for all mCRPC patients to detect HR gene mutations, and consider options for PARP inhibitors,” says Neal Shore, MD, FACS.


Parviz K. Kavoussi, MD

Latest:

Chronic orchialgia: How to diagnose and treat the challenging condition

In this interview, Parviz K. Kavoussi, MD, discusses his diagnostic work-up for patients who present with chronic testicular pain and describes conservative and surgical management approaches for the condition.


Terri Gatchel-Schmidt

Latest:

Expert explains why automation is key to prior authorization reform

Automating prior authorization is an investment that every health care organization should consider. As the industry grapples with rapid regulatory shifts and acute staff shortages, a tailored automation strategy is key to enhancing patient care and improving operational efficiency.



William Furuyama, MD

Latest:

William Furuyama, MD, on community factors’ influence on urinary incontinence

“Having a broader understanding of why someone might be experiencing the disease process or symptoms that they're coming in with is really meaningful and helpful, both to patients and to physicians,” says William Furuyama, MD.


Chelsea King Arthur

Latest:

How data and technology facilitate health equity and boost the overall patient experience

"Digital engagement technology, which can be seamlessly integrated into a health system or hospital's existing processes," writes Chelsea King Arthur.


Karyn S. Eilber, MD

Latest:

OnabotA for OAB: Enhancing comfort and ensuring adherence

Karyn S. Eilber, MD,'s follow-up protocol involves a 2-week post-injection check-up to assess residual urine and the efficacy of the onabotA


Connor M. Forbes, MD

Latest:

Connor Forbes, MD, on trends in surgical procedures for BPH

MIST utilization increased from 7% in 2015 to 51% in 2022 among men aged 50 to 54.


Melissa Kaufman, MD, PhD, FACS

Latest:

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.


Juan J. Andino, MD, MBA

Latest:

Juan Andino, MD, highlights SUO session on telehealth in urology

“Without Congressional action, all the progress that has been made—the new normal, so to speak—that patients, physicians, and providers alike have become used to, is at risk of potentially going back to pre-pandemic, 2019 levels,” says Juan J. Andino, MD, MBA.


Vikram M. Narayan, MD

Latest:

Vikram Narayran, MD, on tech-driven changes that are enhancing patient care

Vikram M. Narayan, MD, discusses Emory's recent shift to Apple products, aimed at reducing physician burnout and improving patient interactions.


Jeunice Owens-Walton, MD

Latest:

Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic

"The use of telemedicine is heavily dependent on supportive legislature," write Tracey L. Krupski, MD, and Jeunice Owens-Walton, MD.


Helen L. Bernie, DO, MPH

Latest:

Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025

Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.


Brian Hudson

Latest:

Is a medical scribe right for your practice?

“Regardless of the size of the practice, medical scribes are a valuable resource for health care providers, helping to streamline workflow and coordinate patient care,” writes Brian Hudson.


Ilaha Isali, MD, MSc

Latest:

Experts discuss review of the microbiome and bladder cancer

"My biggest hope for people reading this review is to understand that there are some golden opportunities for research," says Laura Bukavina, MD, MPH, MSc.

© 2025 MJH Life Sciences

All rights reserved.